Hepatocyte Growth Factor in Predialysis and Hemodialysis Chronic Kidney Disease Patients

Sarat Chandra Vulugundam1, Vinapamula S Kiranmayi2, P V L N Srinivasa Rao2

  • 1Department of Nephrology and Department of Biochemistry Andhra Pradesh, India.

Insights

Hepatocyte growth factor (HGF) levels are elevated in chronic kidney disease (CKD) patients, indicating potential as a biomarker for renal fibrosis. Levels were higher in predialysis CKD patients compared to those on dialysis.

Area of Science:

  • Nephrology
  • Biochemistry
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) is a global health issue marked by declining renal function and fibrosis.
  • Hepatocyte growth factor (HGF) has demonstrated antifibrotic properties in kidney tissues.

Purpose of the Study:

  • To assess Hepatocyte growth factor (HGF) levels in patients with chronic kidney disease (CKD).
  • To investigate the association between HGF and markers of inflammation and oxidative stress in CKD patients.
  • To evaluate HGF as a potential indicator of renal fibrosis in CKD.

Main Methods:

  • Recruited 80 subjects: 20 healthy controls, 40 predialysis CKD patients (stages 1-5), and 20 dialysis CKD patients.
  • Measured serum levels of HGF, high-sensitivity C-reactive protein (hsCRP), malondialdehyde (MDA), and ferric reducing ability of plasma (FRAP).
  • Analyzed HGF levels in relation to CKD stage, dialysis status, and inflammatory/oxidative stress markers.

Main Results:

  • HGF levels were significantly higher in all CKD patients compared to healthy controls.
  • CKD patients exhibited elevated hsCRP, MDA, and FRAP levels, indicating inflammation and oxidative stress.
  • HGF levels were higher in predialysis CKD patients than in dialysis patients, though not statistically significant. No significant correlation was found between HGF and the studied markers.

Conclusions:

  • HGF levels increase in response to renal injury in CKD patients.
  • Elevated HGF suggests a role in renal fibrosis, potentially serving as a biomarker.
  • HGF levels may differentiate between predialysis and dialysis CKD stages, warranting further investigation.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
67
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.5K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
54
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
101
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
76